Pyxis Oncology, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
PYXS on Nasdaq
Industry
Pharmaceutical Preparations
Location
321 Harrison Avenue, Boston, MA

Insiders trading volume in the past year

Pyxis Oncology, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Pfizer Inc 10%+ Owner $16.4M Mar 17, 2023
Pamela Connealy Cfo & Coo $4.99M +$174K +3.62% Mar 31, 2025
Barclays Plc 10%+ Owner $4.87M Apr 26, 2022
Bayer World Investments B.V. Former 10% Owner $3.84M Oct 13, 2021
Cormorant Asset Management, LP Former 10% Owner $1.57M Oct 13, 2021
Jay Feingold Chief Medical Officer $1.09M Mar 24, 2023
Lara Sullivan President ,CEO & CMO, Director $900K Mar 31, 2025
Ken Kobayashi Chief Medical Officer $425K Dec 29, 2023
Jitendra Wadhane SVP, Chief Accounting Officer $259K Mar 31, 2025
Ronald Herbst Chief Scientific Officer $235K Oct 7, 2021
Mark Chin Former Director $162K Apr 21, 2022
Ritu Shah Chief Operating Officer $120K Oct 7, 2021
Santhosh Palani Director $48K Mar 31, 2025
Rachel Humphrey Director $36.2K Mar 31, 2025
Darren Cline Director $36.2K Mar 31, 2025
Freda Lewis-Hall Director $36.2K Mar 31, 2025
John Flavin Director $36.2K Mar 31, 2025
Thomas Civik Director $36.2K Mar 31, 2025
Jakob Dupont Director $36.2K Mar 31, 2025
Michael A. Metzger Director $36.2K Mar 31, 2025

Recent Insider Transactions by Companies or Individuals for Pyxis Oncology, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.